Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Single tender action (below threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £1,500,000 |
Awarded to
| Award value: | £1,500,000 |
| Award decision date: | 12 July 2021 |
| Award status: | Active |
Current Arrangements / Context Building on the 100,000 Genomes Project and existing genetic services, In October 2018 NHS England announced the launch of the NHS Genomic Medicine Service (GMS) which will be mobilised as part of a transition period to take place over 18 months. The long term aims of the Genomic Medicine Service are to: o Provide consistent and equitable care for England's 55 million population o Operate to common national standards, specifications and protocols o Deliver to a single national genomic testing directory - covering use of all technologies from single gene to whole genome sequencing initially for rare disease and cancer o Give all patients the opportunity to participate in research (for individual benefit and to inform future care) o Build a national genomic knowledge base providing real world data This procurement relates to external quality assurance of the samples and the DNA material taken at NHS Genomic Laboratory Hubs as part of the new Genomic Medicine Service. Such sequencing requires high quality DNA and to ensure these samples are provided by the NHS Genomic Medicine Centres (GMCs), a range of external quality assessment (EQA) schemes are required. An assured lab network of GLHs will provide the required assurance to the wider GMS (including for clinical genetics services and Genomic Medicine Centres established as part of the 100,000 Genomes Project). The quality assurance measures are concentrated on 5 major areas. NHS England are obligated to provide a quality assurance service to ensure samples collected are of high enough quality to extract a full genome. The required EQA service is as follows: • EQA for DNA extraction from blood samples • EQA for DNA extraction for formalin fixed paraffin embedded (FFPE) tissue samples • EQA for the measurement of DNA quality • EQA for the assessment of tumour content and cellularity • EQA for the National Genomic Testing Directory
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
1 March 2021
Closed
Estimated Value
£1,500,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Release Date: | 18 April 2023 |
| Application Deadline: | 1 March 2021 |
| Contract Start Date: | 31 March 2021 |
| Contract End Date: | 31 March 2023 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-c6e8d8ae-6b92-4b74-9be1-67a1da7056fe |
| Notice Reference: | 9b166e64-0f97-4c6a-8519-d2df9eec65fb-636918 |
View Original Notice
Access the full notice on the official portal